Unmasking the immune recognition of prostate cancer with CTLA4 blockade. - Wikidata - wikimedia - TriplyDB

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

http://www.wikidata.org/entity/Q37989393

about

Bacteria in Cancer Therapy: Renaissance of an Old Concept Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State Immunotherapy for prostate cancer: recent developments and future challenges Melanoma of non-sun exposed skin in a man with previous prostate cancer: recognition of a recently confirmed association.Immune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancer Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients.Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice Personal history of prostate cancer and increased risk of incident melanoma in the United States.Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor.Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression.A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus.Multiple Tumor Induction after Treatment of Temporal Arteritis with Prednisone.Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patients

P2860

Q26751222-08B1A315-B0C1-4303-9BA3-04A087304067 Q26782573-A7E850B9-1921-48E8-8C55-6E8254C20715 Q26852388-42F9004D-1E29-44DF-88D5-D3016C9E5101 Q33785103-E610AB78-FD41-41BA-A4AB-5E9ED3D4B9BD Q34278246-D4A3C611-798C-4613-9AAF-9B3383779222 Q36020800-6E6CE457-2D91-4528-B936-BF6E95D23C02 Q36303665-10DB8020-B25C-4B1E-A1CE-7344B9A2D011 Q36859227-6DD2A468-9CAA-477E-A8CC-DC4F21FE2AD7 Q37348621-DEFB3C64-9EB8-44ED-AB8B-2E2ED9B9B61E Q37716594-A47F2A5A-17DC-4B3D-97C9-ABD5BBCD1344 Q38185175-0195BEC3-C53C-4B3F-8FBA-32BF2463950A Q38336989-042FC2EC-B680-4A25-A25C-30C82CBAA9A2 Q40626645-04A728BD-635B-4457-B610-29CA16A042F6 Q51065162-67785ACF-E42C-4945-A2FC-4E6682C9DE94 Q55261112-AE0B6958-0D8F-40EB-B634-9FD0A9CA8E6D Q55332826-CDF5C956-4200-4390-9A82-A30C515E56F7 Q56892807-0279AC74-FD69-498C-8AF1-41EDE73AE67D

P2860

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

http://www.wikidata.org/entity/Q37989393

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@en

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@nl

type

label

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@en

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@nl

prefLabel

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@en

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@nl

P1433

Q37989393-83BA1D7E-A6DC-4B08-BA29-55E1F56C2381

P1476

Q37989393-92BE95FA-E451-48EB-A8A8-6C1ED40C498C

P2093

Q37989393-A8DB598B-1D73-4206-9391-88AF1A9AAFAA

Q37989393-C738AF30-955A-4162-8F0F-E06F59350857

Q37989393-FC5043DB-53CF-4986-9CE4-A7D87E4A523B

P2860

Q37989393-00A09247-1E5A-47BD-8204-58B99F68A45F

Q37989393-01533AA6-0EA1-486E-B2B9-5A1FB747E9BA

Q37989393-04CE12F3-D933-4656-B0A8-AA033FC38E81

Q37989393-06AFD86B-4EC7-4A76-9E52-9CFE1920D825

Q37989393-12716611-3F2F-4B3F-92B4-BEA6FC7FCFE3

Q37989393-13B5BACC-34DD-4661-B4FC-9CCE822780C3

Q37989393-1578C01C-B1DB-4616-A698-9F19A0917726

Q37989393-1C101181-2696-40F5-89A2-1A33D170C3BF

Q37989393-1CF2E82D-D6B2-46E4-B4FE-273763CF41F0

Q37989393-1F1F9FEF-0CDD-45E1-BE8C-FE4C64EEC810

P2888

Q37989393-8710F91B-7D46-4E51-929E-FCEFC8F37251

P304

Q37989393-12E16DCA-B9D2-40A8-8FE8-5FA3D95DBF09

P31

Q37989393-5667F703-888D-4618-B3B2-C36BE9902A3A

P356

Q37989393-2F9335D8-5613-4288-BFB8-64CFED92273F

P407

Q37989393-C41A3DAC-FC69-43E2-8196-78B4FFD39447

P433

Q37989393-B556840F-365B-414A-81EB-748CA10E2418

P478

Q37989393-F19F0387-D517-4B35-A3A0-8384E7025D5D

P577

Q37989393-A0491B88-702C-4890-925F-38B7E41EB7A7

P5875

Q37989393-A97F34A7-1D12-4ADB-8022-4619B2136092

P698

Q37989393-0E9C721C-DCB4-4BE6-8AEF-67B4F32225F6

P932

Q37989393-6F485ADC-79E7-46A2-A366-C972BACAFC6A

P356

P1433

Nature Reviews Cancer

P1476

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

@en

P2093

Edward Cha

http://www.w3.org/2001/XMLSchema#string

Lawrence Fong

http://www.w3.org/2001/XMLSchema#string

Serena S Kwek

http://www.w3.org/2001/XMLSchema#string

P2860

Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression

Reversal of the TCR stop signal by CTLA-4

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

Enhancement of antitumor immunity by CTLA-4 blockade

P2888

P304

289-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRC3223

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221873858

http://www.w3.org/2001/XMLSchema#string

P698

22378189

http://www.w3.org/2001/XMLSchema#string

P932

3433280

http://www.w3.org/2001/XMLSchema#string